Primary HPV testing recommendations of US providers, 2015.

Crystale Purvis Cooper, Mona Saraiya
Author Information
  1. Crystale Purvis Cooper: Soltera Center for Cancer Prevention and Control, Tucson, AZ 85704, United States.
  2. Mona Saraiya: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, United States. Electronic address: msaraiya@cdc.gov.

Abstract

OBJECTIVE: To investigate the HPV testing recommendations of US physicians who perform cervical cancer screening.
METHODS: Data from the 2015 DocStyles survey of U.S. health care providers were analyzed using multivariate logistic regression to identify provider characteristics associated with routine recommendation of primary HPV testing for average-risk, asymptomatic women ≥30years old. The analysis was limited to primary care physicians and obstetrician-gynecologists who performed cervical cancer screening (N=843).
RESULTS: Primary HPV testing for average-risk, asymptomatic women ≥30years old was recommended by 40.8% of physicians who performed cervical cancer screening, and 90.1% of these providers recommended primary HPV testing for women of all ages. The screening intervals most commonly recommended for primary HPV testing with average-risk, asymptomatic women ≥30years old were every 3years (35.5%) and annually (30.2%). Physicians who reported that patient HPV vaccination status influenced their cervical cancer screening practices were almost four times more likely to recommend primary HPV testing for average-risk, asymptomatic women ≥30years old than other providers (Adj OR=3.96, 95% CI=2.82-5.57).
CONCLUSION: Many US physicians recommended primary HPV testing for women of all ages, contrary to guidelines which limit this screening approach to women ≥25years old. The association between provider recommendation of primary HPV testing and patient HPV vaccination status may be due to anticipated reductions in the most oncogenic HPV types among vaccinated women.

Keywords

References

  1. Cancer Causes Control. 2016 Apr;27(4):569-81 [PMID: 26970740]
  2. Am J Prev Med. 2014 Sep;47(3):315-9 [PMID: 24953518]
  3. Gynecol Oncol. 2015 Feb;136(2):178-82 [PMID: 25579107]
  4. J Womens Health (Larchmt). 2014 May;23(5):397-403 [PMID: 24380500]
  5. Obstet Gynecol. 2016 Dec;128(6):1265-1273 [PMID: 27824756]
  6. Med J Aust. 2016 Mar 21;204(5):184-184e1 [PMID: 26985843]
  7. Prev Med. 2015 Sep;78:33-7 [PMID: 26116889]
  8. CA Cancer J Clin. 2012 May-Jun;62(3):147-72 [PMID: 22422631]
  9. BMJ. 2008 Oct 13;337:a1754 [PMID: 18852164]
  10. BMJ. 2014 Jan 16;348:g130 [PMID: 24435414]
  11. Cancer Cytopathol. 2014 Nov;122(11):842-50 [PMID: 25045058]
  12. JAMA Oncol. 2017 Jun 1;3(6):833-837 [PMID: 27685805]
  13. Prev Med. 2014 May;62:49-53 [PMID: 24518004]
  14. Int J Cancer. 2013 Dec 15;133(12):2934-43 [PMID: 23754203]
  15. Prev Med. 2017 Feb;95:96-102 [PMID: 27932055]
  16. Obstet Gynecol. 2016 Jan;127(1):e1-e20 [PMID: 26695583]
  17. Obstet Gynecol Clin North Am. 2013 Jun;40(2):257-68 [PMID: 23732030]
  18. Community Health Stud. 1990;14(2):132-7 [PMID: 2208977]
  19. BJOG. 2017 Aug;124(9):1394-1401 [PMID: 28102931]
  20. Int J Cancer. 2016 Dec 1;139(11):2456-66 [PMID: 27538188]
  21. BMJ. 2016 Oct 4;355:i4924 [PMID: 27702796]
  22. Ann Intern Med. 2012 Jun 19;156(12):880-91, W312 [PMID: 22711081]
  23. Am J Obstet Gynecol. 2015 Jan;212(1):62.e1-9 [PMID: 24992692]
  24. Evid Based Med. 2017 Oct;22(5):178 [PMID: 28735278]

Grants

  1. CC999999/Intramural CDC HHS

MeSH Term

Adult
Early Detection of Cancer
Female
Humans
Mass Screening
Middle Aged
Papillomavirus Infections
Physicians, Primary Care
Practice Patterns, Physicians'
Surveys and Questionnaires
Uterine Cervical Neoplasms
Vaccination

Word Cloud

Created with Highcharts 10.0.0HPVtestingwomenscreeningprimarycanceroldphysicianscervicalprovidersaverage-riskasymptomatic≥30yearsrecommendedUSrecommendations2015careproviderrecommendationperformedPrimaryagespatientvaccinationstatusOBJECTIVE:investigateperformMETHODS:DataDocStylessurveyUShealthanalyzedusingmultivariatelogisticregressionidentifycharacteristicsassociatedroutineanalysislimitedobstetrician-gynecologistsN=843RESULTS:408%901%intervalscommonlyevery3years355%annually302%PhysiciansreportedinfluencedpracticesalmostfourtimeslikelyrecommendAdjOR=39695%CI=282-557CONCLUSION:Manycontraryguidelineslimitapproach≥25yearsassociationmaydueanticipatedreductionsoncogenictypesamongvaccinatedCervicalProvidersUnitedStates

Similar Articles

Cited By